Medicare GLP-1 Weight-Loss Drug Coverage Starts July 1: What to Know
Medicare beneficiaries gain access to GLP-1 weight-loss drugs for just $50/month starting July 1. Here's what older Americans should consider first.
Big news if you're on Medicare: starting July 1, qualifying beneficiaries can finally get GLP-1 weight-loss drugs — the same class of medications behind names like Ozempic and Wegovy — covered under the program. The cost comes in at $50 a month, which is a fraction of what these drugs run without insurance. This is the first time Medicare has opened the door to GLP-1s specifically for weight loss.
Before you call your doctor, slow down. These drugs aren't a free pass. Side effects are real and worth understanding before you commit. Nausea, digestive issues, and other reactions hit plenty of users early on, and the experience doesn't improve overnight for everyone.
Read more Mortgage Demand Slumps as Rates Stay Stuck in Tight Range →
Here's the angle that doesn't get enough attention: muscle loss. GLP-1s drive weight down fast, but that weight isn't always fat. Older adults are already at higher risk of losing lean muscle mass — a condition called sarcopenia — and rapid weight loss can accelerate that process. For someone in their 60s or 70s, losing muscle isn't just cosmetic; it affects balance, mobility, and long-term independence.
If you qualify and want in, talk to your doctor about whether resistance training or protein intake adjustments should be part of your plan alongside the medication. The $50 price point makes access real for millions of seniors who couldn't afford these drugs before. That's a genuine game-changer — just go in with both eyes open on what the tradeoffs look like at your age.
Continue reading at MarketWatch.com
